The protective effects of natural products on blood-brain barrier breakdown

Current Medicinal Chemistry

Volumn 19, Issue 12, 2012, Pages 1830-1845

  Kam, A ^a   Li, K M ^b   Razmovski Naumovski, V ^a,c   Nammi, S ^a,c   Chan, K ^a,c   Li, Y ^a   Li, G Q ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Blood brain barrier; Flavonoids; Herbal medicines; Natural products; Neurological disorders; Neuroprotection; Phenolic compounds; Phytochemicals; Structure and activity relationship; Vascular integrity

Indexed keywords

ASTRAGALOSIDE IV; BAICALIN; BERBERINE; CAFFEIC ACID PHENETHYL ESTER; CAFFEINE; COPTIS CHINENSIS EXTRACT; CURCULIGOSIDE A; CURCUMIN; GENISTEIN; GINKGO BILOBA EXTRACT; GINKGOLIDE B; GINSENG EXTRACT; GINSENOSIDE RB 1; HERBACEOUS AGENT; HUPERZIA SERRATA EXTRACT; I KAPPA B KINASE BETA; IRIDOID; LIGUSTILIDE; LIPID; MELISSA OFFICINALIS EXTRACT; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHENOL DERIVATIVE; PINOCEMBRINE; QUERCETIN; RESVERATROL; SALVIA OFFICINALIS EXTRACT; SCUTELLARIA BAICALENSIS EXTRACT; THIOCTIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN ISCHEMIA; COPTIS CHINENSIS; DEGENERATIVE DISEASE; GINKGO BILOBA; GINSENG; HERBAL MEDICINE; HUMAN; MELISSA OFFICINALIS; MULTIPLE SCLEROSIS; NONHUMAN; REPERFUSION INJURY; SALVIA OFFICINALIS; SCUTELLARIA BAICALENSIS; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; STROKE; SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN INJURY;

ANIMALS; BIOLOGICAL AGENTS; BLOOD-BRAIN BARRIER; BRAIN; HUMANS; MODELS, NEUROLOGICAL; MOLECULAR STRUCTURE; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS; PLANTS;

EID: 84860515268     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712800099794     Document Type: Article

References (193)

1. Ehrlich, P. In Collected Studies on Immunity; Wiley: Berlin, 1906.
2. Shlosberg, D.; Benifla, M.; Kaufer, D.; Friedman, A. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat. Rev. Neurol., 2010, 6(7), 393-403.
3. Correale, J.; Villa, A. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting. Autoimmunity, 2007, 40(2), 148-160.
4. Oby, E.; Janigro, D. The blood-brain barrier and epilepsy. Epilepsia, 2006, 47(11), 1761-1774. (Pubitemid 44730046)
5. Petty, M. A.; Lo, E. H. Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog. Neurobiol., 2002, 68(5), 311-323. (Pubitemid 36071509)
6. Medana, I. M.; Turner, G. D. Human cerebral malaria and the blood-brain barrier. Int. J. Parasitol., 2006, 36(5), 555-568. (Pubitemid 43674514)
7. Roberts, T. K.; Buckner, C. M.; Berman, J. W. Leukocyte transmigration across the blood-brain barrier: perspectives on neuroAIDS. Front. Biosci., 2010, 15, 478-536.
8. Weiss, N.; Miller, F.; Cazaubon, S.; Couraud, P. O. The blood-brain barrier in brain homeostasis and neurological diseases. Biochim. Biophys. Acta, 2009, 1788(4), 842-857.
9. Bell, R. D.; Zlokovic, B. V. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol., 2009, 118(1), 103-113.
10. Popescu, B. O.; Toescu, E. C.; Popescu, L. M.; Bajenaru, O.; Muresanu, D. F.; Schultzberg, M.; Bogdanovic, N. Blood-brain barrier alterations in ageing and dementia. J. Neurol. Sci., 2009, 283(1-2), 99-106.
11. Stamatovic, S. M.; Keep, R. F.; Andjelkovic, A. V. Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Curr. Neuropharmacol., 2008, 6(3), 179-192.
12. Zlokovic, B. V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron, 2008, 57(2), 178-201.
13. Arshad, F.; Wang, L.; Sy, C.; Avraham, S.; Avraham, H. K. Blood-brain barrier integrity and breast cancer metastasis to the brain. Patholog. Res. Int., 2010, 2011, 920509.
14. Suk, K. Regulation of neuroinflammation by herbal medicine and its implications for neurodegenerative diseases. A focus on traditional medicines and flavonoids. Neurosignals, 2005, 14(1-2), 23-33. (Pubitemid 40868981)
15. Adams, M.; Gmunder, F.; Hamburger, M. Plants traditionally used in age related brain disorders-a survey of ethnobotanical literature. J. Ethnopharmacol., 2007, 113(3), 363-381. (Pubitemid 47361572)
16. Sucher, N. J. Insights from molecular investigations of traditional Chinese herbal stroke medicines: implications for neuroprotective epilepsy therapy. Epilepsy Behav., 2006, 8(2), 350-362. (Pubitemid 43231227)
17. Breinbauer, R.; Vetter, I. R.; Waldmann, H. From protein domains to drug candidates-natural products as guiding principles in the design and synthesis of compound libraries. Angew. Chem. Int. Ed. Engl., 2002, 41(16), 2879-2890.
18. Abbott, N. J.; Patabendige, A. A.; Dolman, D. E.; Yusof, S. R.; Begley, D. J. Structure and function of the blood-brain barrier. Neurobiol. Dis., 2010, 37(1), 13-25.
19. Cardoso, F. L.; Brites, D.; Brito, M. A. Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches. Brain Res. Rev., 2010, 64(2), 328-363.
20. Rajadhyaksha, M.; Boyden, T.; Liras, J.; El-Kattan, A.; Brodfuehrer, J. Current advances in delivery of biotherapeutics across the blood-brain barrier. Curr. Drug Discov. Technol., 2011, 8(2), 87-101.
21. Toth, A.; Veszelka, S.; Nakagawa, S.; Niwa, M.; Deli, M. A. Patented in vitro blood-brain barrier models in CNS drug discovery. Recent Pat. CNS Drug Discov., 2011, 6(2), 107-118.
22. Wilhelm, I.; Fazakas, C.; Krizbai, I. A. In vitro models of the blood-brain barrier. Acta Neurobiol. Exp. (Wars.), 2011, 71(1), 113-128.
23. Engelhardt, B.; Sorokin, L. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin. Immunopathol., 2009, 31(4), 497-511.
24. Kusuhara, H.; Sugiyama, Y. Active efflux across the blood-brain barrier: role of the solute carrier family. NeuroRx, 2005, 2(1), 73-85. (Pubitemid 40128028)
25. Carvey, P. M.; Hendey, B.; Monahan, A. J. The blood-brain barrier in neurodegenerative disease: a rhetorical perspective. J. Neurochem., 2009, 111(2), 291-314.
26. Persidsky, Y.; Ramirez, S. H.; Haorah, J.; Kanmogne, G. D. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J. Neuroimmune Pharmacol., 2006, 1(3), 223-236. (Pubitemid 44244128)
27. Jiao, H.; Wang, Z.; Liu, Y.; Wang, P.; Xue, Y. Specific Role of Tight Junction Proteins Claudin-5, Occludin, and ZO-1 of the Blood-Brain Barrier in a Focal Cerebral Ischemic Insult. J. Mol. Neurosci., 2011, 44(2), 130-139.
28. Park, S.; Yamaguchi, M.; Zhou, C.; Calvert, J. W.; Tang, J.; Zhang, J. H. Neurovascular protection reduces early brain injury after subarachnoid hemorrhage. Stroke, 2004, 35(10), 2412-2417. (Pubitemid 39311273)
29. Coisne, C.; Engelhardt, B. Tight Junctions in Brain Barriers during CNS Inflammation. Antioxid. Redox Signal, 2011.
30. Omar, E. A.; Kam, A.; Alqahtani, A.; Li, K. M.; Razmovski-Naumovski, V.; Nammi, S.; Chan, K.; Roufogalis, B. D.; Li, G. Q. Herbal medicines and nutraceuticals for diabetic vascular complications: mechanisms of action and bioactive phytochemicals. Curr. Pharm. Des., 2010, 16(34), 3776-3807.
31. Libby, P. Inflammation in atherosclerosis. Nature, 2002, 420(6917), 868-874. (Pubitemid 36019640)
32. Coisne, C.; Lyck, R.; Engelhardt, B. Therapeutic targeting of leukocyte trafficking across the blood-brain barrier. Inflamm. Allergy Drug Targets, 2007, 6(4), 210-222. (Pubitemid 351144584)
33. Dietrich, J. B. The adhesion molecule ICAM-1 and its regulation in relation with the blood-brain barrier. J. Neuroimmunol., 2002, 128(1-2), 58-68.
34. Wong, D.; Prameya, R.; Dorovini-Zis, K. Adhesion and migration of polymorphonuclear leukocytes across human brain microvessel endothelial cells are differentially regulated by endothelial cell adhesion molecules and modulate monolayer permeability. J. Neuroimmunol., 2007, 184(1-2), 136-148. (Pubitemid 46389416)
35. Silva, N. M.; Manzan, R. M.; Carneiro, W. P.; Milanezi, C. M.; Silva, J. S.; Ferro, E. A.; Mineo, J. R. Toxoplasma gondii: the severity of toxoplasmic encephalitis in C57BL/6 mice is associated with increased ALCAM and VCAM-1 expression in the central nervous system and higher blood-brain barrier permeability. Exp. Parasitol., 2010, 126(2), 167-177.
36. Jin, A. Y.; Tuor, U. I.; Rushforth, D.; Kaur, J.; Muller, R. N.; Petterson, J. L.; Boutry, S.; Barber, P. A. Reduced blood brain barrier breakdown in P-selectin deficient mice following transient ischemic stroke: a future therapeutic target for treatment of stroke. BMC Neurosci., 2010, 11, 12.
37. Mark, K. S.; Miller, D. W. Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-alpha exposure. Life Sci., 1999, 64(21), 1941-1953. (Pubitemid 29215195)
38. Trickler, W. J.; Mayhan, W. G.; Miller, D. W. Brain microvessel endothelial cell responses to tumor necrosis factor-alpha involve a nuclear factor kappa B (NF-kappaB) signal transduction pathway. Brain Res., 2005, 1048(1-2), 24-31. (Pubitemid 40800256)
39. de Vries, H. E.; Blom-Roosemalen, M. C.; van Oosten, M.; de Boer, A. G.; van Berkel, T. J.; Breimer, D. D.; Kuiper, J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol., 1996, 64(1), 37-43. (Pubitemid 26052072)
40. Lv, S.; Song, H. L.; Zhou, Y.; Li, L. X.; Cui, W.; Wang, W.; Liu, P. Tumour necrosis factor-alpha affects blood-brain barrier permeability and tight junction-associated occludin in acute liver failure. Liver Int., 2010, 30(8), 1198-1210.
41. Ohara, Y.; McCarron, R. M.; Hoffman, T. T.; Sugano, H.; Bembry, J.; Lenz, F. A.; Spatz, M. Adrenergic mediation of TNF alpha-stimulated ICAM-1 expression on human brain microvascular endothelial cells. Acta Neurochir. Suppl., 2000, 76, 117-120.
42. Guo, S.; Stins, M.; Ning, M.; Lo, E. H. Amelioration of inflammation and cytotoxicity by dipyridamole in brain endothelial cells. Cerebrovasc. Dis., 2010, 30(3), 290-296.
43. Basuroy, S.; Bhattacharya, S.; Leffler, C. W.; Parfenova, H. Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells. Am J Physiol Cell Physiol, 2009, 296(3), C422-432.
44. Blamire, A. M.; Anthony, D. C.; Rajagopalan, B.; Sibson, N. R.; Perry, V. H.; Styles, P. Interleukin-1beta-induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study. J. Neurosci., 2000, 20(21), 8153-8159.
45. Bernardes-Silva, M.; Anthony, D. C.; Issekutz, A. C.; Perry, V. H. Recruitment of neutrophils across the blood-brain barrier: the role of E-and P-selectins. J. Cereb. Blood Flow Metab., 2001, 21(9), 1115-1124. (Pubitemid 32823747)
46. Ferrari, C. C.; Depino, A. M.; Prada, F.; Muraro, N.; Campbell, S.; Podhajcer, O.; Perry, V. H.; Anthony, D. C.; Pitossi, F. J. Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. Am. J. Pathol., 2004, 165(5), 1827-1837. (Pubitemid 39435180)
47. Didier, N.; Romero, I. A.; Creminon, C.; Wijkhuisen, A.; Grassi, J.; Mabondzo, A. Secretion of interleukin-1beta by astrocytes mediates endothelin-1 and tumour necrosis factor-alpha effects on human brain microvascular endothelial cell permeability. J. Neurochem., 2003, 86(1), 246-254. (Pubitemid 36753865)
48. Yamagata, K.; Tagami, M.; Takenaga, F.; Yamori, Y.; Itoh, S. Hypoxiainduced changes in tight junction permeability of brain capillary endothelial cells are associated with IL-1beta and nitric oxide. Neurobiol. Dis., 2004, 17(3), 491-499. (Pubitemid 39574881)
49. Tian, W.; Kyriakides, T. R. Matrix metalloproteinase-9 deficiency leads to prolonged foreign body response in the brain associated with increased IL-1beta levels and leakage of the blood-brain barrier. Matrix Biol., 2009, 28(3), 148-159.
50. McColl, B. W.; Rothwell, N. J.; Allan, S. M. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J. Neurosci., 2008, 28(38), 9451-9462.
51. Sozen, T.; Tsuchiyama, R.; Hasegawa, Y.; Suzuki, H.; Jadhav, V.; Nishizawa, S.; Zhang, J. H. Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke, 2009, 40(7), 2519-2525.
52. Wu, B.; Ma, Q.; Khatibi, N.; Chen, W.; Sozen, T.; Cheng, O.; Tang, J. Ac-YVAD-CMK Decreases Blood-Brain Barrier Degradation by Inhibiting Caspase-1 Activation of Interleukin-1beta in Intracerebral Hemorrhage Mouse Model. Transl. Stroke Res., 2010, 1(1), 57-64.
53. Raslan, F.; Schwarz, T.; Meuth, S. G.; Austinat, M.; Bader, M.; Renne, T.; Roosen, K.; Stoll, G.; Siren, A. L.; Kleinschnitz, C. Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammation. J. Cereb. Blood Flow Metab., 2010, 30(8), 1477-1486.
54. Ding-Zhou, L.; Margaill, I.; Palmier, B.; Pruneau, D.; Plotkine, M.; Marchand-Verrecchia, C. LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia. Br. J. Pharmacol., 2003, 139(8), 1539-1547. (Pubitemid 37174669)
55. Suidan, G. L.; Dickerson, J. W.; Chen, Y.; McDole, J. R.; Tripathi, P.; Pirko, I.; Seroogy, K. B.; Johnson, A. J. CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions. J. Immunol., 2010, 184(2), 1031-1040.
56. Lafuente, J. V.; Bulnes, S.; Mitre, B.; Riese, H. H. Role of VEGF in an experimental model of cortical micronecrosis. Amino Acids, 2002, 23(1-3), 241-245.
57. Shi, W.; Wang, Z.; Pu, J.; Wang, R.; Guo, Z.; Liu, C.; Sun, J.; Gao, L.; Zhou, R. Changes of blood-brain barrier permeability following intracerebral hemorrhage and the therapeutic effect of minocycline in rats. Acta Neurochir. Suppl., 2011, 110(Pt 2), 61-67.
58. Young, P. P.; Fantz, C. R.; Sands, M. S. VEGF disrupts the neonatal bloodbrain barrier and increases life span after non-ablative BMT in a murine model of congenital neurodegeneration caused by a lysosomal enzyme deficiency. Exp. Neurol., 2004, 188(1), 104-114. (Pubitemid 38748809)
59. Ay, I.; Francis, J. W.; Brown, R. H., Jr. VEGF increases blood-brain barrier permeability to Evans blue dye and tetanus toxin fragment C but not adeno-associated virus in ALS mice. Brain Res., 2008, 1234, 198-205.
60. Zhang, Z. G.; Zhang, L.; Jiang, Q.; Zhang, R.; Davies, K.; Powers, C.; Bruggen, N.; Chopp, M. VEGF enhances angiogenesis and promotes bloodbrain barrier leakage in the ischemic brain. J. Clin. Invest., 2000, 106(7), 829-838.
61. Bauer, A. T.; Burgers, H. F.; Rabie, T.; Marti, H. H. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J. Cereb. Blood Flow Metab., 2010, 30(4), 837-848.
62. Ryu, J. K.; McLarnon, J. G. VEGF receptor antagonist Cyclo-VEGI reduces inflammatory reactivity and vascular leakiness and is neuroprotective against acute excitotoxic striatal insult. J. Neuroinflammation, 2008, 5, 18.
63. Davis, B.; Tang, J.; Zhang, L.; Mu, D.; Jiang, X.; Biran, V.; Vexler, Z.; Ferriero, D. M. Role of vasodilator stimulated phosphoprotein in VEGF induced blood-brain barrier permeability in endothelial cell monolayers. Int. J. Dev. Neurosci., 2010, 28(6), 423-428.
64. Wang, W.; Dentler, W. L.; Borchardt, R. T. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am. J. Physiol. Heart Circ. Physiol., 2001, 280(1), H434-440.
65. Nitz, T.; Eisenblatter, T.; Psathaki, K.; Galla, H. J. Serum-derived factors weaken the barrier properties of cultured porcine brain capillary endothelial cells in vitro. Brain Res., 2003, 981(1-2), 30-40. (Pubitemid 37281217)
66. Martinez-Estrada, O. M.; Rodriguez-Millan, E.; Gonzalez-De Vicente, E.; Reina, M.; Vilaro, S.; Fabre, M. Erythropoietin protects the in vitro bloodbrain barrier against VEGF-induced permeability. Eur. J. Neurosci., 2003, 18(9), 2538-2544. (Pubitemid 37452669)
67. Lee, S. W.; Kim, W. J.; Jun, H. O.; Choi, Y. K.; Kim, K. W. Angiopoietin-1 reduces vascular endothelial growth factor-induced brain endothelial permeability via upregulation of ZO-2. Int. J. Mol. Med., 2009, 23(2), 279-284.
68. Argaw, A. T.; Gurfein, B. T.; Zhang, Y.; Zameer, A.; John, G. R. VEGFmediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc. Natl. Acad. Sci. U. S. A., 2009, 106(6), 1977-1982.
69. Liu, W.; Hendren, J.; Qin, X. J.; Shen, J.; Liu, K. J. Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia. J. Neurochem., 2009, 108(3), 811-820.
70. Tsuge, M.; Yasui, K.; Ichiyawa, T.; Saito, Y.; Nagaoka, Y.; Yashiro, M.; Yamashita, N.; Morishima, T. Increase of tumor necrosis factor-alpha in the blood induces early activation of matrix metalloproteinase-9 in the brain. Microbiol. Immunol., 2010, 54(7), 417-424.
71. Sood, R. R.; Taheri, S.; Candelario-Jalil, E.; Estrada, E. Y.; Rosenberg, G. A. Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain. J. Cereb. Blood Flow Metab., 2008, 28(2), 431-438. (Pubitemid 351161291)
72. Hawkins, B. T.; Lundeen, T. F.; Norwood, K. M.; Brooks, H. L.; Egleton, R. D. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia, 2007, 50(1), 202-211. (Pubitemid 46035869)
73. Bonoiu, A.; Mahajan, S. D.; Ye, L.; Kumar, R.; Ding, H.; Yong, K. T.; Roy, I.; Aalinkeel, R.; Nair, B.; Reynolds, J. L.; Sykes, D. E.; Imperiale, M. A.; Bergey, E. J.; Schwartz, S. A.; Prasad, P. N. MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier. Brain Res., 2009, 1282, 142-155.
74. Kawai, N.; Kawanishi, M.; Nagao, S. Treatment of cold injury-induced brain edema with a nonspecific matrix metalloproteinase inhibitor MMI270 in rats. Acta Neurochir. Suppl., 2003, 86, 291-295.
75. Pfefferkorn, T.; Rosenberg, G. A. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke, 2003, 34(8), 2025-2030. (Pubitemid 36944801)
76. Yamaguchi, M.; Jadhav, V.; Obenaus, A.; Colohan, A.; Zhang, J. H. Matrix metalloproteinase inhibition attenuates brain edema in an in vivo model of surgically-induced brain injury. Neurosurgery, 2007, 61(5), 1067-1075; discussion 1075-1066. (Pubitemid 350306967)
77. Wang, J.; Tsirka, S. E. Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage. Brain, 2005, 128(Pt 7), 1622-1633. (Pubitemid 41373681)
78. Pun, P. B.; Lu, J.; Moochhala, S. Involvement of ROS in BBB dysfunction. Free Radic. Res., 2009, 43(4), 348-364.
79. Lochhead, J. J.; McCaffrey, G.; Quigley, C. E.; Finch, J.; De Marco, K. M.; Nametz, N.; Davis, T. P. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxiareoxygenation. J. Cereb. Blood Flow Metab., 2010, 30(9), 1625-1636.
80. Saeed, S. A.; Shad, K. F.; Saleem, T.; Javed, F.; Khan, M. U. Some new prospects in the understanding of the molecular basis of the pathogenesis of stroke. Exp. Brain. Res., 2007, 182(1), 1-10. (Pubitemid 47318241)
81. Noseworthy, M. D.; Bray, T. M. Effect of oxidative stress on brain damage detected by MRI and in vivo 31P-NMR. Free Radic. Biol. Med., 1998, 24(6), 942-951. (Pubitemid 28186234)
82. Allen, C. L.; Bayraktutan, U. Antioxidants attenuate hyperglycaemiamediated brain endothelial cell dysfunction and blood-brain barrier hyperpermeability. Diabetes Obes. Metab., 2009, 11(5), 480-490.
83. Van Gilder, R. L.; Kelly, K. A.; Chua, M. D.; Ptachcinski, R. L.; Huber, J. D. Administration of sesamol improved blood-brain barrier function in streptozotocin-induced diabetic rats. Exp. Brain. Res., 2009, 197(1), 23-34.
84. Deplanque, D.; Gele, P.; Petrault, O.; Six, I.; Furman, C.; Bouly, M.; Nion, S.; Dupuis, B.; Leys, D.; Fruchart, J. C.; Cecchelli, R.; Staels, B.; Duriez, P.; Bordet, R. Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J. Neurosci., 2003, 23(15), 6264-6271. (Pubitemid 36875628)
85. Huang, W.; Eum, S. Y.; Andras, I. E.; Hennig, B.; Toborek, M. PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. FASEB J., 2009, 23(5), 1596-1606.
86. Ramirez, S. H.; Heilman, D.; Morsey, B.; Potula, R.; Haorah, J.; Persidsky, Y. Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses Rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes. J. Immunol., 2008, 180(3), 1854-1865.
87. Klotz, L.; Diehl, L.; Dani, I.; Neumann, H.; von Oppen, N.; Dolf, A.; Endl, E.; Klockgether, T.; Engelhardt, B.; Knolle, P. Brain endothelial PPARgamma controls inflammation-induced CD4+ T cell adhesion and transmigration in vitro. J. Neuroimmunol., 2007, 190(1-2), 34-43. (Pubitemid 47625605)
88. Mestre, L.; Docagne, F.; Correa, F.; Loria, F.; Hernangomez, M.; Borrell, J.; Guaza, C. A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules. Mol. Cell Neurosci., 2009, 40(2), 258-266.
89. Huang, W.; Rha, G. B.; Han, M. J.; Eum, S. Y.; Andras, I. E.; Zhong, Y.; Hennig, B.; Toborek, M. PPARalpha and PPARgamma effectively protect against HIV-induced inflammatory responses in brain endothelial cells. J. Neurochem., 2008, 107(2), 497-509.
90. Yin, K. J.; Deng, Z.; Hamblin, M.; Xiang, Y.; Huang, H.; Zhang, J.; Jiang, X.; Wang, Y.; Chen, Y. E. Peroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury. J. Neurosci., 2010, 30(18), 6398-6408.
91. Feige, J. N.; Gelman, L.; Michalik, L.; Desvergne, B.; Wahli, W. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog. Lipid Res., 2006, 45(2), 120-159. (Pubitemid 43248732)
92. Gardner, O. S.; Dewar, B. J.; Graves, L. M. Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling. Mol. Pharmacol., 2005, 68(4), 933-941. (Pubitemid 41345784)
93. Papageorgiou, E.; Pitulis, N.; Msaouel, P.; Lembessis, P.; Koutsilieris, M. The non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell lines. Expert Opin. Ther. Targets, 2007, 11(8), 1071-1085. (Pubitemid 47240680)
94. Xing, B.; Xin, T.; Hunter, R. L.; Bing, G. Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt. J. Neuroinflammation, 2008, 5, 4.
95. Verrier, E.; Wang, L.; Wadham, C.; Albanese, N.; Hahn, C.; Gamble, J. R.; Chatterjee, V. K.; Vadas, M. A.; Xia, P. PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase. Circ. Res., 2004, 94(11), 1515-1522. (Pubitemid 38780325)
96. Polavarapu, R.; Gongora, M. C.; Winkles, J. A.; Yepes, M. Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation. J. Neurosci., 2005, 25(44), 10094-10100. (Pubitemid 41636205)
97. Zhang, X.; Winkles, J. A.; Gongora, M. C.; Polavarapu, R.; Michaelson, J. S.; Hahm, K.; Burkly, L.; Friedman, M.; Li, X. J.; Yepes, M. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia. J. Cereb. Blood Flow Metab., 2007, 27(3), 534-544.
98. Di, F.; Yan-Ting, G.; Hui, L.; Tao, T.; Zai-Hua, X.; Xue-Ying, S.; Hong-Li, X.; Yun-Jie, W. Role of aminoguanidine in brain protection in surgical brain injury in rat. Neurosci. Lett., 2008, 448(2), 204-207.
99. Wang, Z.; Leng, Y.; Tsai, L. K.; Leeds, P.; Chuang, D. M. Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J. Cereb. Blood Flow Metab., 2011, 31(1), 52-57.
100. Chen, G.; Zhang, S.; Shi, J.; Ai, J.; Qi, M.; Hang, C. Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway. Exp. Neurol., 2009, 216(2), 398-406.
101. Feng, X.; Zhang, F.; Dong, R.; Wang, H.; Liu, J.; Liu, X.; Li, W.; Yao, J.; Xu, J.; Yu, B. Effects of hydroxyethyl starch (130 kD) on brain inflammatory response and outcome during normotensive sepsis. Int. Immunopharmacol., 2010, 10(8), 859-864.
102. Prasad, R.; Giri, S.; Nath, N.; Singh, I.; Singh, A. K. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction. J. Neurosci. Res., 2006, 84(3), 614-625. (Pubitemid 44196702)
103. Tripathi, A. K.; Sullivan, D. J.; Stins, M. F. Plasmodium falciparum-infected erythrocytes increase intercellular adhesion molecule 1 expression on brain endothelium through NF-kappaB. Infect Immun, 2006, 74(6), 3262-3270. (Pubitemid 43794513)
104. Wang, Y. H.; Wang, W. Y.; Chang, C. C.; Liou, K. T.; Sung, Y. J.; Liao, J. F.; Chen, C. F.; Chang, S.; Hou, Y. C.; Chou, Y. C.; Shen, Y. C. Taxifolin ameliorates cerebral ischemia-reperfusion injury in rats through its antioxidative effect and modulation of NF-kappa B activation. J. Biomed. Sci., 2006, 13(1), 127-141. (Pubitemid 43162511)
105. Prasad, R.; Giri, S.; Nath, N.; Singh, I.; Singh, A. K. Inhibition of phosphoinositide 3 kinase-Akt (protein kinase B)-nuclear factor-kappa B pathway by lovastatin limits endothelial-monocyte cell interaction. J. Neurochem., 2005, 94(1), 204-214. (Pubitemid 40911406)
106. Lu, H.; Shi, J. X.; Zhang, D. M.; Shen, J.; Lin, Y. X.; Hang, C. H.; Yin, H. X. Hemolysate-induced expression of intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 expression in cultured brain microvascular endothelial cells via through ROS-dependent NF-kappaB pathways. Cell Mol. Neurobiol., 2009, 29(1), 87-95.
107. Thornton, P.; McColl, B. W.; Cooper, L.; Rothwell, N. J.; Allan, S. M. Interleukin-1 drives cerebrovascular inflammation via MAP kinaseindependent pathways. Curr. Neurovasc. Res., 2010, 7(4), 330-340.
108. Huang, W.; Rha, G. B.; Chen, L.; Seelbach, M. J.; Zhang, B.; Andras, I. E.; Bruemmer, D.; Hennig, B.; Toborek, M. Inhibition of telomerase activity alters tight junction protein expression and induces transendothelial migration of HIV-1-infected cells. Am. J. Physiol. Heart Circ. Physiol., 2010, 298(4), H1136-1145.
109. Hoffman, W. H.; Stamatovic, S. M.; Andjelkovic, A. V. Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis. Brain Res., 2009, 1254, 138-148.
110. Pfeilschifter, W.; Czech, B.; Hoffmann, B. P.; Sujak, M.; Kahles, T.; Steinmetz, H.; Neumann-Haefelin, T.; Pfeilschifter, J. Pyrrolidine dithiocarbamate activates p38 MAPK and protects brain endothelial cells from apoptosis: a mechanism for the protective effect in stroke? Neurochem. Res., 2010, 35(9), 1391-1401.
111. Basuroy, S.; Bhattacharya, S.; Tcheranova, D.; Qu, Y.; Regan, R. F.; Leffler, C. W.; Parfenova, H. HO-2 provides endogenous protection against oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells. Am J Physiol Cell Physiol, 2006, 291(5), C897-908. (Pubitemid 44771809)
112. Wang, J. K.; Yu, L. N.; Zhang, F. J.; Yang, M. J.; Yu, J.; Yan, M.; Chen, G. Postconditioning with sevoflurane protects against focal cerebral ischemia and reperfusion injury via PI3K/Akt pathway. Brain Res., 2010, 1357, 142-151.
113. Wang, X.; Li, B.; Zhao, W. D.; Liu, Y. J.; Shang, D. S.; Fang, W. G.; Chen, Y. H. Perfluorooctane sulfonate triggers tight junction "opening" in brain endothelial cells via phosphatidylinositol 3-kinase. Biochem. Biophys. Res. Commun., 2011, 410(2), 258-263.
114. Willis, C. L.; Meske, D. S.; Davis, T. P. Protein kinase C activation modulates reversible increase in cortical blood-brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation. J. Cereb. Blood Flow Metab., 2010, 30(11), 1847-1859.
115. Cui, G. Y.; Gao, X. M.; Qi, S. H.; Gillani, A.; Gao, L.; Shen, X.; Zhang, Y. D. The action of thrombin in intracerebral hemorrhage induced brain damage is mediated via PKCalpha/PKCdelta signaling. Brain Res., 2010.
116. Qiu, L. B.; Ding, G. R.; Li, K. C.; Wang, X. W.; Zhou, Y.; Zhou, Y. C.; Li, Y. R.; Guo, G. Z. The role of protein kinase C in the opening of blood-brain barrier induced by electromagnetic pulse. Toxicology, 2010, 273(1-3), 29-34.
117. Fleegal, M. A.; Hom, S.; Borg, L. K.; Davis, T. P. Activation of PKC modulates blood-brain barrier endothelial cell permeability changes induced by hypoxia and posthypoxic reoxygenation. Am. J. Physiol. Heart Circ. Physiol., 2005, 289(5), H2012-2019. (Pubitemid 41507352)
118. Cui, L.; Zhang, X.; Yang, R.; Wang, L.; Liu, L.; Li, M.; Du, W. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability. Brain Res., 2010, 1325, 164-173.
119. Nito, C.; Kamada, H.; Endo, H.; Niizuma, K.; Myer, D. J.; Chan, P. H. Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion. J. Cereb. Blood Flow Metab., 2008, 28(10), 1686-1696.
120. Suzuki, H.; Hasegawa, Y.; Kanamaru, K.; Zhang, J. H. Mechanisms of osteopontin-induced stabilization of blood-brain barrier disruption after subarachnoid hemorrhage in rats. Stroke, 2010, 41(8), 1783-1790.
121. Liu, C. X.; Xiao, P. G. Recent advances on ginseng research in China. J. Ethnopharmacol., 1992, 36(1), 27-38.
122. Izzo, A. A.; Capasso, F. Herbal medicines to treat Alzheimer's disease. Trends Pharmacol. Sci., 2007, 28(2), 47-48. (Pubitemid 46161833)
123. Akhondzadeh, S.; Abbasi, S. H. Herbal medicine in the treatment of Alzheimer's disease. Am. J. Alzheimers Dis. Other. Demen., 2006, 21(2), 113-118.
124. da Rocha, M. D.; Viegas, F. P.; Campos, H. C.; Nicastro, P. C.; Fossaluzza, P. C.; Fraga, C. A.; Barreiro, E. J.; Viegas, C., Jr. The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders II: Alzheimer's disease. CNS Neurol. Disord. Drug Targets, 2011, 10(2), 251-270.
125. Simonyi, A.; Wang, Q.; Miller, R. L.; Yusof, M.; Shelat, P. B.; Sun, A. Y.; Sun, G. Y. Polyphenols in cerebral ischemia: novel targets for neuroprotection. Mol. Neurobiol., 2005, 31(1-3), 135-147. (Pubitemid 41271199)
126. Wu, P. F.; Zhang, Z.; Wang, F.; Chen, J. G. Natural compounds from traditional medicinal herbs in the treatment of cerebral ischemia/reperfusion injury. Acta Pharmacol. Sin., 2010, 31(12), 1523-1531.
127. Tsang, C. M.; Lau, E. P.; Di, K.; Cheung, P. Y.; Hau, P. M.; Ching, Y. P.; Wong, Y. C.; Cheung, A. L.; Wan, T. S.; Tong, Y.; Tsao, S. W.; Feng, Y. Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. Int. J. Mol. Med., 2009, 24(1), 131-138.
128. Ma, X.; Jiang, Y.; Wu, A.; Chen, X.; Pi, R.; Liu, M.; Liu, Y. Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice. PLoS One, 2010, 5(10), e13489.
129. Huang, C.; Zhang, Y.; Gong, Z.; Sheng, X.; Li, Z.; Zhang, W.; Qin, Y. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway. Biochem. Biophys. Res. Commun., 2006, 348(2), 571-578. (Pubitemid 44209153)
130. Amasheh, M.; Fromm, A.; Krug, S. M.; Amasheh, S.; Andres, S.; Zeitz, M.; Fromm, M.; Schulzke, J. D. TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling. J. Cell. Sci., 2010, 123(Pt 23), 4145-4155.
131. Benowitz, N. L. Clinical pharmacology of caffeine. Annu. Rev. Med., 1990, 41, 277-288. (Pubitemid 20121734)
132. Chen, X.; Gawryluk, J. W.; Wagener, J. F.; Ghribi, O.; Geiger, J. D. Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease. J. Neuroinflammation, 2008, 5, 12.
133. Toklu, H. Z.; Hakan, T.; Biber, N.; Solakoglu, S.; Ogunc, A. V.; Sener, G. The protective effect of alpha lipoic acid against traumatic brain injury in rats. Free Radic. Res., 2009, 43(7), 658-667.
134. Chaudhary, P.; Marracci, G. H.; Bourdette, D. N. Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis. J. Neuroimmunol., 2006, 175(1-2), 87-96.
135. Chou, T. C.; Shih, C. Y.; Chen, Y. T. Inhibitory effect of alpha-lipoic acid on platelet aggregation is mediated by PPARs. J. Agric. Food Chem., 2011, 59(7), 3050-3059.
136. Wang, H.; Li, W.; Li, J.; Rendon-Mitchell, B.; Ochani, M.; Ashok, M.; Yang, L.; Yang, H.; Tracey, K. J.; Wang, P.; Sama, A. E. The aqueous extract of a popular herbal nutrient supplement, Angelica sinensis, protects mice against lethal endotoxemia and sepsis. J. Nutr., 2006, 136(2), 360-365. (Pubitemid 43230174)
137. Chen, D.; Tang, J.; Khatibi, N. H.; Zhu, M.; Li, Y.; Wang, C.; Jiang, R.; Tu, L.; Wang, S. Treatment with Z-ligustilide, a component of Angelica sinensis, reduces brain injury after a subarachnoid hemorrhage in rats. J. Pharmacol. Exp. Ther., 2011, 337(3), 663-672.
138. Tu, X. K.; Yang, W. Z.; Liang, R. S.; Shi, S. S.; Chen, J. P.; Chen, C. M.; Wang, C. H.; Xie, H. S.; Chen, Y.; Ouyang, L. Q. Effect of Baicalin on Matrix Metalloproteinase-9 Expression and Blood-Brain Barrier Permeability Following Focal Cerebral Ischemia in Rats. Neurochem. Res., 2011.
139. Zhu, H.; Wang, Z.; Xing, Y.; Gao, Y.; Ma, T.; Lou, L.; Lou, J.; Wang, S.; Wang, Y. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells. J. Ethnopharmacol., 2011.
140. Huang, G.; Cao, X.; Zhang, X.; Chang, H.; Yang, Y.; Du, W.; Wilson, J. X. Effects of soybean isoflavone on the notch signal pathway of the brain in rats with cerebral ischemia. J. Nutr. Sci. Vitaminol. (Tokyo), 2009, 55(4), 326-331.
141. Schreihofer, D. A.; Redmond, L. Soy phytoestrogens are neuroprotective against stroke-like injury in vitro. Neuroscience, 2009, 158(2), 602-609.
142. Malinowska, M.; Wilkinson, F. L.; Langford-Smith, K. J.; Langford-Smith, A.; Brown, J. R.; Crawford, B. E.; Vanier, M. T.; Grynkiewicz, G.; Wynn, R. F.; Wraith, J. E.; Wegrzyn, G.; Bigger, B. W. Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease. PLoS One, 2010, 5(12), e14192.
143. Mayhan, W. G. Cellular mechanisms by which tumor necrosis factor-alpha produces disruption of the blood-brain barrier. Brain Res., 2002, 927(2), 144-152. (Pubitemid 34124121)
144. Mueller, M.; Hobiger, S.; Jungbauer, A. Red clover extract: a source for substances that activate peroxisome proliferator-activated receptor alpha and ameliorate the cytokine secretion profile of lipopolysaccharide-stimulated macrophages. Menopause, 2010, 17(2), 379-387.
145. Dang, Z. C.; Audinot, V.; Papapoulos, S. E.; Boutin, J. A.; Lowik, C. W. Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. J. Biol. Chem., 2003, 278(2), 962-967. (Pubitemid 36790772)
146. Meng, F.; Liu, R.; Gao, M.; Wang, Y.; Yu, X.; Xuan, Z.; Sun, J.; Yang, F.; Wu, C.; Du, G. Pinocembrin attenuates blood-brain barrier injury induced by global cerebral ischemia-reperfusion in rats. Brain Res., 2011, 1391, 93-101.
147. Gao, M.; Zhu, S. Y.; Tan, C. B.; Xu, B.; Zhang, W. C.; Du, G. H. Pinocembrin protects the neurovascular unit by reducing inflammation and extracellular proteolysis in MCAO rats. J. Asian. Nat. Prod. Res., 2010, 12(5), 407-418.
148. Russo, M.; Spagnuolo, C.; Tedesco, I.; Bilotto, S.; Russo, G. L. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem. Pharmacol., 2012, 83(1), 6-15.
149. Lee, J. K.; Kwak, H. J.; Piao, M. S.; Jang, J. W.; Kim, S. H.; Kim, H. S. Quercetin reduces the elevated matrix metalloproteinases-9 level and improves functional outcome after cerebral focal ischemia in rats. Acta Neurochir. (Wien.), 2010, 153(6), 1321-1329.
150. Chuang, C. C.; Martinez, K.; Xie, G.; Kennedy, A.; Bumrungpert, A.; Overman, A.; Jia, W.; McIntosh, M. K. Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes. Am. J. Clin. Nutr., 2010, 92(6), 1511-1521.
151. Jiang, J.; Wang, W.; Sun, Y. J.; Hu, M.; Li, F.; Zhu, D. Y. Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage. Eur. J. Pharmacol., 2007, 561(1-3), 54-62. (Pubitemid 46435844)
152. Zhang, L.; Gu, Z. L.; Qin, Z. H.; Liang, Z. Q. Effect of curcumin on the adhesion of platelets to brain microvascular endothelial cells in vitro. Acta Pharmacol. Sin., 2008, 29(7), 800-807.
153. Xu, J.; Fu, Y.; Chen, A. Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am. J. Physiol. Gastrointest. Liver Physiol., 2003, 285(1), G20-30. (Pubitemid 36736384)
154. Wang, H. M.; Zhao, Y. X.; Zhang, S.; Liu, G. D.; Kang, W. Y.; Tang, H. D.; Ding, J. Q.; Chen, S. D. PPARgamma agonist curcumin reduces the amyloidbetastimulated inflammatory responses in primary astrocytes. J. Alzheimers Dis., 2010, 20(4), 1189-1199.
155. Jiang, W.; Fu, F.; Tian, J.; Zhu, H.; Hou, J. Curculigoside A attenuates experimental cerebral ischemia injury in vitro and vivo. Neuroscience, 2011, 192, 572-579.
156. Jiang, W. L.; Tian, J. W.; Fu, F. H.; Zhu, H. B.; Hou, J. Neuroprotective efficacy and therapeutic window of Forsythoside B: in a rat model of cerebral ischemia and reperfusion injury. Eur. J. Pharmacol., 2010, 640(1-3), 75-81.
157. Lin, Y. L.; Chang, H. C.; Chen, T. L.; Chang, J. H.; Chiu, W. T.; Lin, J. W.; Chen, R. M. Resveratrol protects against oxidized LDL-induced breakage of the blood-brain barrier by lessening disruption of tight junctions and apoptotic insults to mouse cerebrovascular endothelial cells. J. Nutr., 2010, 140(12), 2187-2192.
158. Chang, H. C.; Chen, T. G.; Tai, Y. T.; Chen, T. L.; Chiu, W. T.; Chen, R. M. Resveratrol attenuates oxidized LDL-evoked Lox-1 signaling and consequently protects against apoptotic insults to cerebrovascular endothelial cells. J. Cereb. Blood Flow Metab., 2011, 31(3), 842-854.
159. Kennedy, A.; Overman, A.; Lapoint, K.; Hopkins, R.; West, T.; Chuang, C. C.; Martinez, K.; Bell, D.; McIntosh, M. Conjugated linoleic acidmediated inflammation and insulin resistance in human adipocytes are attenuated by resveratrol. J. Lipid Res., 2009, 50(2), 225-232.
160. Ge, H.; Zhang, J. F.; Guo, B. S.; He, Q.; Wang, B. Y.; He, B.; Wang, C. Q. Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARgamma. Vascul. Pharmacol., 2007, 46(2), 114-121. (Pubitemid 44937681)
161. Jiang, W.; Zhang, S.; Fu, F.; Zhu, H.; Hou, J. Inhibition of nuclear factorkappaB by 6-O-acetyl shanzhiside methyl ester protects brain against injury in a rat model of ischemia and reperfusion. J. Neuroinflammation, 2010, 7, 55.
162. Xie, W.; Du, L. Diabetes is an inflammatory disease: evidence from traditional Chinese medicines. Diabetes Obes. Metab., 2011, 13(4), 289-301.
163. Qu, Y. Z.; Li, M.; Zhao, Y. L.; Zhao, Z. W.; Wei, X. Y.; Liu, J. P.; Gao, L.; Gao, G. D. Astragaloside IV attenuates cerebral ischemia-reperfusioninduced increase in permeability of the blood-brain barrier in rats. Eur. J. Pharmacol., 2009, 606(1-3), 137-141.
164. Birks, J.; Grimley Evans, J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst. Rev., 2007(2), CD003120.
165. Yoshikawa, T.; Naito, Y.; Kondo, M. Ginkgo biloba leaf extract: review of biological actions and clinical applications. Antioxid. Redox Signal, 1999, 1(4), 469-480. (Pubitemid 129628310)
166. Diamond, B. J.; Shiflett, S. C.; Feiwel, N.; Matheis, R. J.; Noskin, O.; Richards, J. A.; Schoenberger, N. E. Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys. Med. Rehabil., 2000, 81(5), 668-678. (Pubitemid 30257692)
167. Sharma, H. S.; Drieu, K.; Alm, P.; Westman, J. Role of nitric oxide in bloodbrain barrier permeability, brain edema and cell damage following hyperthermic brain injury. An experimental study using EGB-761 and Gingkolide B pretreatment in the rat. Acta Neurochir. Suppl., 2000, 76, 81-86.
168. Yan, F. L.; Zheng, Y.; Zhao, F. D. Effects of ginkgo biloba extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia. Acta Neuropathol., 2008, 116(5), 529-535.
169. Xu, J. P.; Rui, Y. C.; Li, T. J. Antagonistic effects of Ginkgo biloba extract on adhesion of monocytes and neutrophils to cultured cerebral microvascular endothelial cells. Zhongguo Yao Li Xue Bao, 1999, 20(5), 423-425.
170. Li, Y.; Tang, J.; Khatibi, N. H.; Zhu, M.; Chen, D.; Zheng, W.; Wang, S. Ginsenoside Rbeta1 reduces neurologic damage, is anti-apoptotic, and downregulates p53 and BAX in subarachnoid hemorrhage. Curr. Neurovasc. Res., 2010, 7(2), 85-94.
171. Mohagheghi, F.; Bigdeli, M. R.; Rasoulian, B.; Hashemi, P.; Pour, M. R. The neuroprotective effect of olive leaf extract is related to improved blood-brain barrier permeability and brain edema in rat with experimental focal cerebral ischemia. Phytomedicine, 2011, 18(2-3), 170-175.
172. Martin, R.; Carvalho-Tavares, J.; Hernandez, M.; Arnes, M.; Ruiz-Gutierrez, V.; Nieto, M. L. Beneficial actions of oleanolic acid in an experimental model of multiple sclerosis: a potential therapeutic role. Biochem. Pharmacol., 2010, 79(2), 198-208.
173. Lee, H. K.; Nam, G. W.; Kim, S. H.; Lee, S. H. Phytocomponents of triterpenoids, oleanolic acid and ursolic acid, regulated differently the processing of epidermal keratinocytes via PPAR-alpha pathway. Exp. Dermatol., 2006, 15(1), 66-73.
174. Christensen, K. B.; Jorgensen, M.; Kotowska, D.; Petersen, R. K.; Kristiansen, K.; Christensen, L. P. Activation of the nuclear receptor PPARgamma by metabolites isolated from sage (Salvia officinalis L.). J. Ethnopharmacol., 2010, 132(1), 127-133.
175. Huang, T. H.; Peng, G.; Kota, B. P.; Li, G. Q.; Yamahara, J.; Roufogalis, B. D.; Li, Y. Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids. Br. J. Pharmacol., 2005, 145(6), 767-774. (Pubitemid 41076283)
176. Cheng, T. O. Cardiovascular effects of Danshen. Int. J. Cardiol., 2007, 121(1), 9-22. (Pubitemid 47287779)
177. Zhou, L.; Zuo, Z.; Chow, M. S. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J. Clin. Pharmacol., 2005, 45(12), 1345-1359. (Pubitemid 41643896)
178. Zhang, W. J.; Feng, J.; Zhou, R.; Ye, L. Y.; Liu, H. L.; Peng, L.; Lou, J. N.; Li, C. H. Tanshinone IIA protects the human blood-brain barrier model from leukocyte-associated hypoxia-reoxygenation injury. Eur. J. Pharmacol., 2010, 648(1-3), 146-152.
179. Wang, L.; Zhang, X.; Liu, L.; Cui, L.; Yang, R.; Li, M.; Du, W. Tanshinone II A down-regulates HMGB1, RAGE, TLR4, NF-kappaB expression, ameliorates BBB permeability and endothelial cell function, and protects rat brains against focal ischemia. Brain Res., 2010, 1321, 143-151.
180. Tang, C.; Xue, H.; Bai, C.; Fu, R.; Wu, A. The effects of Tanshinone IIA on blood-brain barrier and brain edema after transient middle cerebral artery occlusion in rats. Phytomedicine, 2010, 17(14), 1145-1149.
181. Tang, C.; Xue, H. L.; Bai, C. L.; Fu, R. Regulation of adhesion molecules expression in TNF-alpha-stimulated brain microvascular endothelial cells by tanshinone IIA: involvement of NF-kappaB and ROS generation. Phytother. Res., 2011, 25(3), 376-380.
182. Gong, Z.; Huang, C.; Sheng, X.; Zhang, Y.; Li, Q.; Wang, M. W.; Peng, L.; Zang, Y. Q. The role of tanshinone IIA in the treatment of obesity through peroxisome proliferator-activated receptor gamma antagonism. Endocrinology, 2009, 150(1), 104-113.
183. Kapadia, R.; Yi, J. H.; Vemuganti, R. Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front. Biosci., 2008, 13, 1813-1826. (Pubitemid 351599735)
184. Urquiaga, I.; Leighton, F. Plant polyphenol antioxidants and oxidative stress. Biol. Res., 2000, 33(2), 55-64.
185. Kaneko, T.; Baba, N.; Matsuo, M. Structure-activity relationship of antioxidants for inhibitors of linoleic acid hydroperoxide-induced toxicity in cultured human umbilical vein endothelial cells. Cytotechnology, 2001, 35(1), 43-55. (Pubitemid 32304976)
186. Kaneko, T.; Baba, N. Protective effect of flavonoids on endothelial cells against linoleic acid hydroperoxide-induced toxicity. Biosci. Biotechnol. Biochem., 1999, 63(2), 323-328. (Pubitemid 129548678)
187. Yi, L.; Jin, X.; Chen, C. Y.; Fu, Y. J.; Zhang, T.; Chang, H.; Zhou, Y.; Zhu, J. D.; Zhang, Q. Y.; Mi, M. T. Chemical Structures of 4-Oxo-Flavonoids in Relation to Inhibition of Oxidized Low-Density Lipoprotein (LDL)-Induced Vascular Endothelial Dysfunction. Int. J. Mol. Sci., 2011, 12(9), 5471-5489.
188. Lotito, S. B.; Frei, B. Dietary flavonoids attenuate tumor necrosis factor alpha-induced adhesion molecule expression in human aortic endothelial cells. Structure-function relationships and activity after first pass metabolism. J. Biol. Chem., 2006, 281(48), 37102-37110. (Pubitemid 46042180)
189. Chacko, B. K.; Chandler, R. T.; D'Alessandro, T. L.; Mundhekar, A.; Khoo, N. K.; Botting, N.; Barnes, S.; Patel, R. P. Anti-inflammatory effects of isoflavones are dependent on flow and human endothelial cell PPARgamma. J. Nutr., 2007, 137(2), 351-356. (Pubitemid 46213448)
190. Frank, R. N. Diabetic retinopathy. N. Engl. J. Med., 2004, 350(1), 48-58. (Pubitemid 38032183)
191. Lucas, R.; Verin, A. D.; Black, S. M.; Catravas, J. D. Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. Biochem. Pharmacol., 2009, 77(12), 1763-1772.
192. Xu, J.; Anuar, F.; Ali, S. M.; Ng, M. Y.; Phua, D. C.; Hunziker, W. Zona occludens-2 is critical for blood-testis barrier integrity and male fertility. Mol. Biol. Cell, 2009, 20(20), 4268-4277.
193. Mannarino, E.; Pirro, M. Endothelial injury and repair: a novel theory for atherosclerosis. Angiology, 2008, 59(2 Suppl), 69S-72S.